Check-Cap Ltd. (NASDAQ:CHEK) Short Interest Up 1,041.4% in January

Check-Cap Ltd. (NASDAQ:CHEK) saw a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 113,000 shares, a growth of 1,041.4% from the December 31st total of 9,900 shares. Approximately 2.6% of the company’s shares are sold short. Based on an average daily volume of 1,210,000 shares, the days-to-cover ratio is currently 0.1 days.

Check-Cap Stock Performance

Check-Cap stock traded down $0.13 during mid-day trading on Tuesday, hitting $1.06. The company’s stock had a trading volume of 83,915 shares, compared to its average volume of 1,930,554. The company has a 50 day moving average of $1.05 and a 200-day moving average of $1.43. Check-Cap has a one year low of $0.56 and a one year high of $3.45. The stock has a market cap of $6.20 million, a PE ratio of -0.35 and a beta of 0.17.

Wall Street Analyst Weigh In

Separately, StockNews.com initiated coverage on Check-Cap in a research report on Tuesday. They set a “sell” rating for the company.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.